Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC | MicrobiomeTrials← Back to trialsNCT06100705
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-12-20Est. Completion: 2027-12
Enrollment target: 26 participants Locations- Yale Cancer Center, New Haven, Connecticut, United States
Other microbiome trials you might be interested in
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate CancerProstate Carcinoma
This is a single-center, open-label, study of Prostate-Specific Membrane Antigen (PSMA)-targeted radionuclide therapy wi…
San Francisco, United StatesEst. completion May 31, 2027
Hormone-refractory Prostate Cancer
The study will be conducted in 4 parts and will commence with dose escalation of VIR-5500 as a monotherapy (Part 1), fol…
Orange, United StatesEst. completion Sep 29, 2027
Prostate Cancer Metastatic
This is a Phase 1/2 multicenter, open-label, dose finding and dose expansion study of ADI-212 in participants with metas…
Redwood City, United StatesEst. completion Oct 2028